Prostate cancer is a rapidly expanding area for radiopharmaceutical therapy, primarily driven by prostate-specific membrane ...
Correlation of Tumor Absorbed Dose with Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer Treated with 177 Lu-PSMA ...
Thyroid cancer is the most common cancer of the head and neck region and affects 3 times as many women as men. The most indicated treatment for differentiated thyroid carcinoma (DTC) is partial or ...
Journal of Nuclear Medicine Technology April 2026, jnmt.126.272482; DOI: https://doi.org/10.2967/jnmt.126.272482 ...
The Prostate Cancer Working Group 4 guidelines (PCWG4) represent a significant evolution in the framework used to evaluate prostate cancer progression and treatment response in clinical trials.
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Today’s common practice of empiric activity prescription in radiopharmaceutical therapy is inconsistent with the modern philosophy of personalized medicine. We investigate the radiobiologic ...
Journal of Nuclear Medicine Technology February 2026, jnmt.125.271265; DOI: https://doi.org/10.2967/jnmt.125.271265 ...
Key terminology related to theranostics in prostate cancer has been consolidated into concise reference tables. The definitions are simplified to emphasize practical clinical understanding and working ...
We present the case report of a patient with a history of lung cancer in whom the typical pattern of hypertrophic osteoarthropathy was seen on bone scintigraphy. We discuss the etiologies, ...
We report a case of rare incidental initial detection of unsuspected arterial supply compromise to the right lower extremity on a bone scan obtained to rule out fracture in a patient with right hip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results